SENSITIVITY OF PET MEASUREMENTS WITH C-11 RACLOPRIDE TO CHANGES IN ENDOGENOUS DOPAMINE

被引：0
|
作者：
VOLKOW, ND
FOWLER, JS
WANG, GJ
SCHLYER, D
LOGAN, J
DEWEY, SL
HITZEMANN, R
ANGRIST, B
LIEBERMANN, J
MACGREGOR, RR
WOLF, AP
机构：
[1] BROOKHAVEN NATL LAB,DEPT MED,UPTON,NY 11973
[2] BROOKHAVEN NATL LAB,DEPT CHEM,UPTON,NY 11973
来源：
JOURNAL OF NUCLEAR MEDICINE | 1993年 / 34卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：P67 / P67
页数：1
相关论文
共 50 条
  • [1] Simultaneous modeling of [C-11]raclopride PET and dopamine microdialysis
    Endres, CJ
    Carson, RE
    Kolachana, B
    Su, T
    Saunders, R
    Eckelman, WC
    Breier, A
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 298 - 298
  • [2] IMAGING ENDOGENOUS DOPAMINE COMPETITION WITH [C-11] RACLOPRIDE IN THE HUMAN BRAIN
    VOLKOW, ND
    WANG, GJ
    FOWLER, JS
    LOGAN, J
    SCHLYER, D
    HITZEMANN, R
    LIEBERMAN, J
    ANGRIST, B
    PAPPAS, N
    MACGREGOR, R
    BURR, G
    COOPER, T
    WOLF, AP
    SYNAPSE, 1994, 16 (04) : 255 - 262
  • [3] PET ANALYSIS OF HUMAN DOPAMINE RECEPTOR SUBTYPES USING C-11 SCH 23390 AND C-11 RACLOPRIDE
    FARDE, L
    HALLDIN, C
    STONEELANDER, S
    SEDVALL, G
    PSYCHOPHARMACOLOGY, 1987, 92 (03) : 278 - 284
  • [4] Serotonergic modulation of dopamine measured with [C-11]raclopride and PET in normal human subjects
    Smith, GS
    Dewey, SL
    Brodie, JD
    Logan, J
    Vitkun, SA
    Simkowitz, P
    Schloesser, R
    Alexoff, DA
    Hurley, A
    Cooper, T
    Volkow, ND
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (04): : 490 - 496
  • [5] IN-VIVO ESTIMATES OF SYNAPTIC DOPAMINE CONCENTRATIONS WITH C-11 RACLOPRIDE/PET - A DIRECT TEST OF THE DOPAMINE HYPOTHESIS
    BREIER, A
    CARSON, R
    ECKELMAN, W
    DEBARTOLOMEIS, A
    SAUNDERS, RC
    WEINBERGER, D
    SU, TP
    PICKAR, D
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 76 - 77
  • [6] GABAERGIC INHIBITION OF ENDOGENOUS DOPAMINE RELEASE MEASURED INVIVO WITH C-11 RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY
    DEWEY, SL
    SMITH, GS
    LOGAN, J
    BRODIE, JD
    YU, DW
    FERRIERI, RA
    KING, PT
    MACGREGOR, RR
    MARTIN, TP
    WOLF, AP
    VOLKOW, ND
    FOWLER, JS
    MELLER, E
    JOURNAL OF NEUROSCIENCE, 1992, 12 (10): : 3773 - 3780
  • [7] Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [C-11]raclopride displacement and PET
    Tedroff, J
    Pedersen, M
    Aquilonius, SM
    Hartvig, P
    Jacobsson, G
    Langstrom, B
    NEUROLOGY, 1996, 46 (05) : 1430 - 1436
  • [8] STRIATAL DOPAMINE D-2 RECEPTORS IN PATIENTS WITH NARCOLEPSY MEASURED WITH PET AND C-11 RACLOPRIDE
    KHAN, N
    ANTONINI, A
    PARKES, D
    DAHLITZ, MJ
    MEIEREWERT, K
    WEINDL, A
    LEENDERS, KL
    NEUROLOGY, 1994, 44 (11) : 2101 - 2104
  • [9] PET study of competition between intravenous cocaine and [C-11]raclopride at dopamine receptors in human subjects
    Schlaepfer, TE
    Pearlson, GD
    Wong, DF
    Marenco, S
    Dannals, RF
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (09): : 1209 - 1213
  • [10] STRIATAL BINDING OF THE PET LIGAND C-11 RACLOPRIDE IS ALTERED BY DRUGS THAT MODIFY SYNAPTIC DOPAMINE LEVELS
    DEWEY, SL
    SMITH, GS
    LOGAN, J
    BRODIE, JD
    FOWLER, JS
    WOLF, AP
    SYNAPSE, 1993, 13 (04) : 350 - 356
12345